Intravitreal triamcinolone acetonide in serpiginous choroidopathy [2]

Indian Journal of Ophthalmology

Volumn 53, Issue 1, 2005, Pages 77-79

  Pathengay, Avinash ^a  

^a L V PRASAD EYE INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; TRIAMCINOLONE ACETONIDE;

ADULT; CASE REPORT; CHORIORETINOPATHY; CHRONIC INFLAMMATION; CLINICAL FEATURE; COMORBIDITY; CORTICOSTEROID THERAPY; DRUG CONTRAINDICATION; DRUG HALF LIFE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAOCULAR PRESSURE; LETTER; MALE; OPHTHALMOSCOPY; PEPTIC ULCER; REMISSION; SERPIGINOUS CHOROIDOPATHY; VISUAL ACUITY; VISUAL DISORDER;

EID: 17144395133     PISSN: 03014738     EISSN: None     Source Type: Journal    
DOI: 10.4103/0301-4738.15295     Document Type: Letter

References (4)

1. Weiss H, Annesly WJ, Shields JA. The clinical course of serpiginous choroidopathy. Am J Ophthalmol 1979;87:133-42.
2. Hooper PL, Kaplan HJ. Triple agent immunosuppression in serpiginous choroiditis. Ophthalmology 1991;98:944-51.
3. th Ed. McGraw-Hill, Inc. 1994. Vol. 2, pp 1363-81.
4. Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, ffytche TJ, Marshall J. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 2001;108:765-72.